Literature DB >> 3079242

The histopathology of graft-versus-host disease.

E R Farmer1.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3079242

Source DB:  PubMed          Journal:  Adv Dermatol        ISSN： 0882-0880


× No keyword cloud information.
  3 in total

1.  Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.

Authors:  Mehdi Hamadani; Michael Craig; Gary S Phillips; Jame Abraham; William Tse; Aaron Cumpston; Laura Gibson; Scot C Remick; Pamela Bunner; Sonia Leadmon; Patrick Elder; Craig Hofmeister; Sam Penza; Yvonne Efebera; Leslie Andritsos; Ramiro Garzon; Don M Benson; William Blum; Steven M Devine
Journal:  Hematol Oncol       Date:  2011-02-28       Impact factor: 5.271

2.  Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.

Authors:  Mehdi Hamadani; William Blum; Gary Phillips; Patrick Elder; Leslie Andritsos; Craig Hofmeister; Lynn O'Donnell; Rebecca Klisovic; Sam Penza; Ramiro Garzon; David Krugh; Thomas Lin; Thomas Bechtel; Don M Benson; John C Byrd; Guido Marcucci; Steven M Devine
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-01       Impact factor: 5.742

3.  Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin.

Authors:  Lauren Veltri; Michael Regier; Aaron Cumpston; Sonia Leadmon; William Tse; Michael Craig; Mehdi Hamadani
Journal:  Bone Marrow Res       Date:  2013-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.